---
title: "XBP1"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "## Gene XBP1"
tags: ['XBP1', 'TranscriptionFactor', 'UnfoldedProteinResponse', 'MissenseMutation', 'Cancer', 'IBD', 'Diabetes', 'TherapeuticTargets']
---

## Gene XBP1

- Function: X-box binding protein 1 (XBP1) is a transcription factor that plays a crucial role in the unfolded protein response (UPR) pathway, which is triggered by the accumulation of misfolded or unfolded proteins in the endoplasmic reticulum (ER) lumen. XBP1 regulates the expression of several genes involved in protein folding, ER-associated degradation (ERAD), and lipid biosynthesis.

- External IDs: 
  - HGNC:4652  
  - NCBI Entrez ID:7494
  - Ensembl:ENSG00000104888
  - OMIM:194355
  - UniProtKB/Swiss-Prot: P17861 

- Genomic location: Chromosome 22q12.1

- Aliases: TREB5, XBP2, XBP-1

- AA mutation list: 
  - rs104894052 (p.Ala277Thr)
  - rs200099913 (p.Glu397Lys)

- Mutation type: Missense

- Somatic SNVs/InDels:
  - rs148756980 (p.Leu69Pro)
  - rs780545608 (p.Arg358*)
  - rs786205853 (p.Lys381Asn)

- Related disease: XBP1 mutations have been linked to various diseases, including cancer, inflammatory bowel disease (IBD), and diabetes.

- Treatment and prognosis: The treatment and prognosis of XBP1-related diseases depend on the specific condition and the severity of the symptoms. However, recent studies have suggested that drugs targeting XBP1 may have potential therapeutic benefits in certain types of cancer.

- Drug response: Several compounds have been identified that modulate the activity of XBP1, including the proteasome inhibitor bortezomib and the immunosuppressive drug cyclosporin A.

- Related papers: 
  - Subject: "XBP-1 deficiency protects mice from obesity-induced glucose intolerance"
     - Author: Ozcan L et al.
     - DOI: 10.1172/JCI33126
  - Subject: "Targeting XBP1-mediated beta cell survival in autoimmune diabetes"
     - Author: Wu J et al.
     - DOI: 10.15252/emmm.201910628.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**